The Hydrophobic Patch Directs Cyclin B to Centrosomes to Promote Global CDK Phosphorylation at Mitosis.


Journal

Current biology : CB
ISSN: 1879-0445
Titre abrégé: Curr Biol
Pays: England
ID NLM: 9107782

Informations de publication

Date de publication:
09 03 2020
Historique:
received: 29 07 2019
revised: 20 11 2019
accepted: 17 12 2019
pubmed: 23 2 2020
medline: 5 5 2021
entrez: 22 2 2020
Statut: ppublish

Résumé

The cyclin-dependent kinases (CDKs) are the major cell-cycle regulators that phosphorylate hundreds of substrates, controlling the onset of S phase and M phase [1-3]. However, the patterns of substrate phosphorylation increase are not uniform, as different substrates become phosphorylated at different times as cells proceed through the cell cycle [4, 5]. In fission yeast, the correct ordering of CDK substrate phosphorylation can be established by the activity of a single mitotic cyclin-CDK complex [6, 7]. Here, we investigate the substrate-docking region, the hydrophobic patch, on the fission yeast mitotic cyclin Cdc13 as a potential mechanism to correctly order CDK substrate phosphorylation. We show that the hydrophobic patch targets Cdc13 to the yeast centrosome equivalent, the spindle pole body (SPB), and disruption of this motif prevents both centrosomal localization of Cdc13 and the onset of mitosis but does not prevent S phase. CDK phosphorylation in mitosis is compromised for approximately half of all mitotic CDK substrates, with substrates affected generally being those that require the highest levels of CDK activity to become phosphorylated and those that are located at the SPB. Our experiments suggest that the hydrophobic patch of mitotic cyclins contributes to CDK substrate selection by directing the localization of Cdc13-CDK to centrosomes and that this localization of CDK contributes to the CDK substrate phosphorylation necessary to ensure proper entry into mitosis. Finally, we show that mutation of the hydrophobic patch prevents cyclin B1 localization to centrosomes in human cells, suggesting that this mechanism of cyclin-CDK spatial regulation may be conserved across eukaryotes.

Identifiants

pubmed: 32084401
pii: S0960-9822(19)31686-0
doi: 10.1016/j.cub.2019.12.053
pmc: PMC7063568
pii:
doi:

Substances chimiques

CCNB1 protein, human 0
Cyclin B1 0
Schizosaccharomyces pombe Proteins 0
Cyclin-Dependent Kinases EC 2.7.11.22

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

883-892.e4

Subventions

Organisme : Wellcome Trust
ID : 214183
Pays : United Kingdom
Organisme : Cancer Research UK
ID : FC01121
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : FC001121
Pays : United Kingdom
Organisme : Wellcome Trust
ID : FC01121
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : FC01121
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Cell Rep. 2018 Jul 10;24(2):503-514
pubmed: 29996109
J Cell Biol. 2019 Apr 1;218(4):1108-1117
pubmed: 30674583
Mol Cell Proteomics. 2016 Jul;15(7):2448-61
pubmed: 27134283
Nature. 2005 May 26;435(7041):507-12
pubmed: 15917811
J Cell Sci. 2003 Oct 15;116(Pt 20):4119-30
pubmed: 12972503
Science. 2003 May 9;300(5621):987-90
pubmed: 12738867
Mol Biol Cell. 2007 Dec;18(12):4847-58
pubmed: 17881737
Nat Biotechnol. 2006 Jul;24(7):841-7
pubmed: 16823372
Nature. 1996 Jul 25;382(6589):325-31
pubmed: 8684460
Philos Trans R Soc Lond B Biol Sci. 2011 Dec 27;366(1584):3625-34
pubmed: 22084388
Cell. 1994 Sep 9;78(5):813-22
pubmed: 8087848
Nat Cell Biol. 2003 Feb;5(2):143-8
pubmed: 12524548
Cell. 2016 Dec 15;167(7):1750-1761.e16
pubmed: 27984725
Mol Cell. 2019 Jul 11;75(1):76-89.e3
pubmed: 31101497
Nature. 2003 Oct 23;425(6960):859-64
pubmed: 14574415
J Cell Biol. 2001 Mar 5;152(5):945-58
pubmed: 11238451
Nat Struct Mol Biol. 2019 Jul;26(7):649-658
pubmed: 31270471
Genes Dev. 2004 May 1;18(9):981-91
pubmed: 15105375
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):2932-7
pubmed: 20133761
Curr Biol. 2013 Feb 4;23(3):213-22
pubmed: 23333317
Open Biol. 2014 Jul;4(7):
pubmed: 24990387
Philos Trans R Soc Lond B Biol Sci. 2014 Sep 5;369(1650):
pubmed: 25047606
J Cell Sci. 2001 Jul;114(Pt 14):2627-40
pubmed: 11683390
Mol Cell. 2015 Nov 5;60(3):446-59
pubmed: 26527280
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Biol Methods. 2014;1(2):
pubmed: 25606571
Mol Biol Cell. 1999 Aug;10(8):2771-85
pubmed: 10436027
Genes Dev. 2011 Apr 15;25(8):863-74
pubmed: 21498573
J Cell Sci. 2009 Nov 15;122(Pt 22):4168-76
pubmed: 19910498
EMBO J. 1996 Feb 15;15(4):850-60
pubmed: 8631306
Dev Cell. 2010 Apr 20;18(4):533-43
pubmed: 20412769
Nature. 2005 Mar 3;434(7029):104-8
pubmed: 15744308
Nature. 2010 Dec 23;468(7327):1074-9
pubmed: 21179163
Nature. 2000 Sep 21;407(6802):395-401
pubmed: 11014197
Mol Cell. 2011 Aug 5;43(3):406-17
pubmed: 21816347
Philos Trans R Soc Lond B Biol Sci. 2014 Sep 5;369(1650):
pubmed: 25047608
J Cell Sci. 1992 Mar;101 ( Pt 3):529-45
pubmed: 1387877
Nat Commun. 2015 Apr 20;6:6871
pubmed: 25891897
Nat Rev Mol Cell Biol. 2007 Jul;8(7):530-41
pubmed: 17585314
Dev Cell. 2017 Oct 23;43(2):141-156.e7
pubmed: 29065306
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10453-8
pubmed: 9724724
Mol Cell. 2011 Jun 10;42(5):610-23
pubmed: 21658602
Nature. 2007 Aug 16;448(7155):811-5
pubmed: 17700700
J Cell Biol. 1998 Dec 14;143(6):1603-16
pubmed: 9852154
Nat Cell Biol. 2013 Jan;15(1):88-95
pubmed: 23222840

Auteurs

Souradeep Basu (S)

Cell Cycle Laboratory, The Francis Crick Institute, London NW1 1AT, UK. Electronic address: saz.basu@crick.ac.uk.

Emma L Roberts (EL)

Cell Cycle Laboratory, The Francis Crick Institute, London NW1 1AT, UK.

Andrew W Jones (AW)

Cell Cycle Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Protein Analysis and Proteomics Platform, The Francis Crick Institute, London NW1 1AT, UK.

Matthew P Swaffer (MP)

Cell Cycle Laboratory, The Francis Crick Institute, London NW1 1AT, UK.

Ambrosius P Snijders (AP)

Protein Analysis and Proteomics Platform, The Francis Crick Institute, London NW1 1AT, UK.

Paul Nurse (P)

Cell Cycle Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Laboratory of Yeast Genetics and Cell Biology, Rockefeller University, New York, NY 10065, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH